80 likes | 87 Views
Capitalstars is a best Investment & share market Advisory Company in India. We provide accurate Intraday Tips, Free Tips, free intraday tips.<br>http://www.capitalstars.com/bullion-premium-mcx-tips/<br>
E N D
CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 02 NDAUGUST 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report INDIAN FACE INDIAN MARKET CLOSE PREVIOUS ! 37481.12 INDIAN EQUITY BENCHMARK - The final hour recovery helped the Nifty to close around 11,000 level and Sensex above 37,000 after remained under immense selling NIFTY 11118.00 pressure throughout the day. At close, the Sensex was down CLOSE PREVIOUS 462.80 points at 37,018.32, while Nifty was down 138 points NIKKEI 21521.53 at 10,980. About 830 shares have advanced, 1587 shares declined, and 147 shares are unchanged. Vedanta, JSW Steel, 27777.75 Hindalco Industries, SBI and Tata Motors were among major 2017.34 2024.55 losers on the Nifty, while gainers were Wipro, Bharti Infratel, SECTORIAL INDICES Maruti Suzuki, Reliance Industries and Power Grid Corp. CLOSE CHANGE (%) Among sectors, except energy all other indices ended on CNX 100 11080.90 -1.25 weak note led by the metal (down 3 percent), PSU bank S&P CNX 500 -1.25 (down 2 percent), IT (down 1.8 percent) followed by infra, pharma and FMCG. GLOBAL FACE -1.22 CNX 200 -1.23 BANK NIFTY 28367.25 -1.76 ! Asian Market - Asian markets finished mixed as of the most recent closing prices. The Nikkei 225 gained 0.09%, while the TOP GAINERS CLOSE CHANGE (%) Shanghai Composite led the Hang Seng lower. They fell 0.81% and 0.73% respectively. MARUTI WIPRO ! U.S. Market – North and South American markets finished broadly lower on Wednesday with shares in Brazil leading the region. The Bovespa is down 1.09% while U.S.'s S&P 500 is off 1.09% and Mexico's IPC is lower by 0.72%. TOP LOSERS ! CLOSE CHANGE (%) European markets – European markets are mixed today. The CAC 40 is up 0.48% while the DAX gains 0.25%. The FTSE 100 is off 0.23%. 225.55 -5.01 SBIN 316.60 -4.70 129.70 -4.35 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NIFTY SPOT MARKET MOVERS UPSIDE SCRIPT CLOSE STRATEGY SELL ON RISE (%) 2.13 MARUTI PIVOT POINTS P 10979 S3 S2 10783 S1 R1 R2 11175 RESISTANCE R1-11100 R2-11250 R3 11370 1.67 RELIANCE 10587 10881 11077 0.93 EICHERMOT SUPPORT S1-10820 S2-10700 TITAN 0.53 CLOSE (%) VEDL HINDALCO NET BUY (CR.) NET INSTITUTION SELL (CR) TREND STRATEGY SELL ON RISE FII 7432.29 PIVOT POINTS P 28550 SUPPORT S1-28300 S2-28100 4006.73 S2 27766 S1 28176 R2 R3 30117 26983 28959 29333 RESISTANCE R1-28800 R2-29000 NSE TOTALS BANK NIFTY DECLINE S INDICES NIFTY 0 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report ! ! Marico's adj. PAT up 26% yoy to Rs320cr for Q1FY20 RBI Monetary Policy Preview: Expecting a 25bps rate cut Since the last policy, data and trends emerging indicate that inflation continues to be stable and is trending on the lower side. Further, growth has been muted on account of visible consumption slowdown as well as subdued investment outlook. Despite a late start, we have seen that the monsoon has reasonably caught up, which should give a boost to agriculture and lead to the revival to some extent of consumption in rural India. Globally, we have seen negative yields in certain countries and overall interest rates are stable or dropping and growth has slowed. Against this backdrop, the central bank is likely to cut the repo rate by 25 bps. It will be important to study the policy narrative to get a direction of likely future action by the RBI, liquidity measures, any other structural changes etc. Suffice it to say that inflation will be the central theme balanced with the need to boost growth. Marico reported strong earnings growth for Q1FY20. Revenue from operations grew 7% yoy to Rs2,166cr with an underlying domestic volume growth of 6% and constant currency growth of 7% in the international business.There was a one-time trade inventory correction in the Gulf business. Adjusting for the same, constant currency growth in the International business stood at 9%. Easing raw material costs in the domestic and key overseas markets led to gross margin expansion of 524bps on a yoy basis. EBITDA margin expanded 324 bps, as the Company stepped up A&P spends by 32% to support its core and new franchises. ! Godrej Consumer Products up 2%; reports Rs291cr adj. PAT for Q1FY20 Godrej Consumer Products reported its Q1FY20 numbers today. The cons. net profit came in at Rs408cr, just 1% yoy higher than that in Q1FY19. Without exceptional and one- off items, it stood at Rs291cr and vs. Rs313cr in Q1FY20. The company's net sales on a constant currency basis grew 4% yoy. Its India business sales grew 1% yoy and 5% yoy in volume terms. International business sales grew 9% yoy, on a constant currency basis The consolidated constant currency EBITDA rose 8% yoy to Rs301cr. ! Biocon, Mylan launch first Trastuzumab Biosimilar, Ogivri, in Australia Biocon Ltd. and Mylan N.V. announced the launch in Australia of Ogivri (trastuzumab), a biosimilar to Herceptin 1 (trastuzumab), for the treatment of HER2-overexpressing breast cancer and metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma). . Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NAME OF THE STOCK : AJANTPHARM DATE : 02/08/2019 SEGMENT : CASH CHART TYPE : Candlestick EXCHANGE : NSE TECHNICAL INDICATORS USED : VOLUME.MACD,RSI. CHART INVESTMENT ADVICE: CALL CS CALL:- BUY AJANTPHARM IN CASH ABOVE 956 TGT 974 SL 938 RATIONALE FOR ARRIVING INVESTMENT ADVICE : TECHNICAL VIEW : THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE. OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. CapitalStars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. CapitalStars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Mcx Tips Financial advisory company Sharemarket company Stock Tips Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647
CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.